Workflow
万东医疗(600055) - 2023 Q1 - 季度财报
600055WDM(600055)2023-04-27 16:00

Financial Performance - The company's operating revenue for Q1 2023 was ¥255,084,691.08, representing a year-on-year increase of 21.12%[6] - The net profit attributable to shareholders for Q1 2023 was ¥30,438,016.42, reflecting a year-on-year growth of 23.57%[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥29,282,857.58, up 24.34% year-on-year[6] - Total revenue for Q1 2023 reached ¥255,084,691.08, a 21.1% increase from ¥210,601,112.63 in Q1 2022[24] - Operating profit for Q1 2023 was ¥35,458,280.90, compared to ¥30,482,372.71 in Q1 2022, reflecting an increase of 16.4%[27] - Net profit for Q1 2023 amounted to ¥29,673,219.40, up from ¥25,382,468.15 in Q1 2022, representing a growth of 16.5%[29] - The company reported a total comprehensive income of ¥29,673,219.40 for Q1 2023, compared to ¥25,382,468.15 in Q1 2022, reflecting an increase of 16.5%[29] Cash Flow - The net cash flow from operating activities was -¥44,623,764.36, a decrease of 74.35% compared to the same period last year[6] - Cash flow from operating activities showed a net outflow of ¥44,623,764.36 in Q1 2023, worsening from a net outflow of ¥25,595,019.71 in Q1 2022[31] - Net cash flow from investing activities was -153,040,931.44,comparedto153,040,931.44, compared to 128,582,285.46 in the previous period[32] - Total cash inflow from financing activities reached 2,090,259,364.94,whilecashoutflowwas2,090,259,364.94, while cash outflow was 636,779.93, resulting in a net cash flow of 2,053,539,364.94[32]Theendingcashandcashequivalentsbalancewas2,053,539,364.94[32] - The ending cash and cash equivalents balance was 3,033,170,415.68, down from 3,231,471,891.41atthebeginningoftheperiod[32]Cashinflowfrominvestmentactivitiestotaled3,231,471,891.41 at the beginning of the period[32] - Cash inflow from investment activities totaled 50,831,601.16, significantly lower than 162,717,036.16inthepreviousperiod[32]Cashoutflowforcapitalexpenditureswas162,717,036.16 in the previous period[32] - Cash outflow for capital expenditures was 3,872,532.60, compared to 1,134,750.70inthepreviousperiod[32]Thecompanyreceived1,134,750.70 in the previous period[32] - The company received 50,000,000.00 from investment recoveries, down from $155,500,000.00 previously[32] - The company reported a significant increase in cash inflow from financing activities, primarily due to new investments received[32] Assets and Liabilities - Total assets at the end of Q1 2023 amounted to ¥5,270,779,752.96, showing a slight increase of 0.16% from the end of the previous year[9] - The equity attributable to shareholders at the end of Q1 2023 was ¥4,635,842,013.21, which is a 0.66% increase from the previous year-end[9] - The total current assets were CNY 4,273,359,853.97, showing a marginal increase from CNY 4,266,343,912.23[20] - The total current liabilities decreased to CNY 470,583,949.12 from CNY 492,076,591.29, a reduction of about 4.4%[22] - The non-current assets totaled CNY 997,419,898.99, slightly up from CNY 996,255,263.50[22] - The total liabilities were CNY 486,248,381.68, down from CNY 507,740,023.85, indicating a decrease of approximately 4.2%[22] - Total liabilities as of Q1 2023 were ¥530,488,831.82, a decrease from ¥551,981,473.99 in the previous year[24] - Total equity attributable to shareholders reached ¥4,635,842,013.21 in Q1 2023, up from ¥4,605,403,996.79 in Q1 2022[24] Earnings and Expenses - The company's basic earnings per share for Q1 2023 was ¥0.043, down 6.52% year-on-year[6] - The weighted average return on equity for Q1 2023 was 0.66%, a decrease of 0.36% compared to the same period last year[6] - Research and development expenses increased to ¥28,849,435.87 in Q1 2023, compared to ¥24,860,818.21 in Q1 2022, marking a rise of 15.9%[27] - Sales expenses rose to ¥47,730,558.94 in Q1 2023, up from ¥39,339,624.00 in Q1 2022, indicating a 21.5% increase[27] Financial Assets - The increase in trading financial assets by 149.50% was due to the use of temporarily idle funds to purchase financial products[12] - The company reported a decrease in cash flow from investing activities by 219.02% due to the purchase of financial products with temporarily idle funds[12] - The company reported a significant increase in financial assets, with trading financial assets rising to CNY 250,422,580.82 from CNY 100,369,008.22, a growth of about 149.5%[20] Related Party Transactions - The company has not disclosed any related party relationships among the top shareholders, indicating no known concerted actions as per the regulations[18]